Adipose Tissue: A Tertiary Lymphoid Organ: Does It Change with Age?


Journal

Gerontology
ISSN: 1423-0003
Titre abrégé: Gerontology
Pays: Switzerland
ID NLM: 7601655

Informations de publication

Date de publication:
2020
Historique:
received: 15 03 2019
accepted: 10 07 2019
pubmed: 15 8 2019
medline: 2 10 2020
entrez: 15 8 2019
Statut: ppublish

Résumé

In this manuscript, we summarize published results showing that obesity and aging are inflammatory conditions associated with serious health problems, increased risk for disease and death. We show that fat mass increases with age and represents a major contributor to insulin resistance and the metabolic syndrome. We summarize the effects of age on the adipose tissue (AT), related to the abundance, distribution, cellular composition, endocrine signaling and function of the tissue. The AT is an immunological tissue, with several hallmarks of innate and adaptive immune responses. We show that in both mice and humans, the AT is heavily infiltrated by immune cells that have receptors for pro-inflammatory cytokines and chemokines secreted by the adipocytes and also by the immune cells that have infiltrated the AT. We also show that the AT provides an environment for the secretion of IgG antibodies with anti-self (autoimmune) reactivity. As we have previously shown, this is due to the release of self antigens following cell death due to hypoxia, as well as to the expression of activation-induced cytidine deaminase, the enzyme of class switch recombination, and the transcription factor T-bet by the resident B cells, which also express the membrane marker CD11c, both involved in the production of autoimmune IgG antibodies. We show data in support of the AT as a tertiary lymphoid organ (TLO), showing the examples of TLOs that develop within the AT, such as fat-associated lymphoid clusters and milky spots, as well as artery TLOs that develop in the adventitia areas of the aorta.

Identifiants

pubmed: 31412335
pii: 000502036
doi: 10.1159/000502036
pmc: PMC7018534
mid: NIHMS1042073
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

114-121

Subventions

Organisme : NIA NIH HHS
ID : R01 AG023717
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG032576
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG059719
Pays : United States

Informations de copyright

© 2019 S. Karger AG, Basel.

Références

Curr Opin Genet Dev. 2011 Feb;21(1):107-12
pubmed: 21093253
Exp Gerontol. 1999 Jul;34(4):491-501
pubmed: 10817805
Clin Anat. 2007 Nov;20(8):933-42
pubmed: 17879305
Anat Rec. 1995 Feb;241(2):163-74
pubmed: 7710133
Obesity (Silver Spring). 2016 Mar;24(3):615-25
pubmed: 26857091
Hypertension. 2011 Nov;58(5):784-90
pubmed: 21931075
Nature. 1998 Oct 22;395(6704):763-70
pubmed: 9796811
J Immunol. 2011 Feb 1;186(3):1849-60
pubmed: 21187439
Biogerontology. 2016 Feb;17(1):7-19
pubmed: 25921609
Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1174-85
pubmed: 27102965
Obesity (Silver Spring). 2015 Mar;23(3):512-8
pubmed: 25612251
Nutr Res Rev. 2008 Dec;21(2):117-33
pubmed: 19087366
Aging Cell. 2010 Oct;9(5):667-84
pubmed: 20701600
Nat Immunol. 2013 Oct;14(10):986-95
pubmed: 24048120
J Clin Invest. 2007 Jan;117(1):175-84
pubmed: 17200717
FASEB J. 2008 Oct;22(10):3450-7
pubmed: 18566293
J Immunol. 2009 Apr 1;182(7):4237-43
pubmed: 19299722
J Immunol. 2001 Sep 15;167(6):3231-8
pubmed: 11544310
J Immunol. 2002 Jun 1;168(11):5893-9
pubmed: 12023394
Cardiovasc Pathol. 2018 Jan - Feb;32:8-14
pubmed: 29078120
J Exp Med. 2019 Apr 1;216(4):786-806
pubmed: 30862706
Exp Gerontol. 2014 Jun;54:116-22
pubmed: 24440385
Front Immunol. 2016 Oct 10;7:387
pubmed: 27777573
Autoimmun Rev. 2014 Sep;13(9):981-1000
pubmed: 25092612
Nature. 2017 Oct 5;550(7674):119-123
pubmed: 28953873
Int J Obes (Lond). 2017 Feb;41(2):348-351
pubmed: 27899808
Obesity (Silver Spring). 2008 Nov;16(11):2424-30
pubmed: 18719675
Mech Ageing Dev. 2014 Mar-Apr;136-137:129-37
pubmed: 24321378
Front Immunol. 2016 Nov 09;7:491
pubmed: 27881983
Front Immunol. 2016 Dec 27;7:646
pubmed: 28082981
Nat Immunol. 2015 Aug;16(8):819-828
pubmed: 26147686
Int J Obes Relat Metab Disord. 1999 Feb;23(2):126-32
pubmed: 10078845
MAGMA. 2005 Jul;18(3):128-37
pubmed: 16001284
J Clin Invest. 2014 Mar;124(3):953-9
pubmed: 24590281
F1000Res. 2017 Feb 28;6:196
pubmed: 28344775
J Immunol. 2007 Oct 1;179(7):4829-39
pubmed: 17878382
Ann N Y Acad Sci. 2000 Jun;908:244-54
pubmed: 10911963
Trends Immunol. 2012 Jun;33(6):297-305
pubmed: 22622061
Arthritis Res. 2000;2(6):457-63
pubmed: 11094459
PLoS One. 2018 May 16;13(5):e0197472
pubmed: 29768501

Auteurs

Daniela Frasca (D)

Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA, dfrasca@med.miami.edu.

Bonnie B Blomberg (BB)

Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA.
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH